Impact of metformin therapy in patients with polycystic ovarian syndrome

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 11, 2005, Pages 712-715

  Hasan, Jahan Ara ^a,b   Memon, Ghufrana Umer ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Anovulation; Hyperinsulinemia; Metformin; Polycystic ovarian syndrome (PCOS); Serum fasting insulin levels

Indexed keywords

FOLIC ACID; GLUCOSE; INSULIN; METFORMIN;

ADULT; ARTICLE; BLOATING; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MENSTRUAL CYCLE; NAUSEA; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PAKISTAN; PREGNANCY; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME;

EID: 30544446305     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jakubowicz DJ, Ivorno MJ, Jakubowicz S, Roberts KA, Nestuer JE, Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metabo 2002; 87: 524-9.
2. Robert L, Barbieri MD. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am J Obstet Gynaecol 2000; 183: 1412-8.
3. Lord JM, Flight IH, Norman RJ, Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951-3.
4. Eagleson CA, Bellows AB, Kathyhu, Gingrich MB, Marshall JC. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore. sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. J Clin Endocrinol Metab 2003, 88: 5158-65.
5. Nestler JE, Bar Lascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, et al. Suppression of serum insulin by diazoxide reduce serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1989; 68: 1027-32.
6. Nagi DK, Yudkn JS, Effects of metformin on insulin resistance, risk factors for cardiovascular disease and plasminogen activator inhibitor in niddm subjects: a study of two ethnic groups. Diabetes Care 1993; 16: 621-9.
7. Moghetti P, Castello R, Negri C, Tusi F, Perrone F, Caputo M, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome. A randomized, double blind, placebo-controlled 6 months trial, followed by open long-term clinical evaluation. J Clin Endocrinol Metab 2000; 89: 139-46.
8. Nestuer JE, Jakubowicz DJ, Evans WS, Pasqual R. Effects of metformin on spontaneous and clomiphene induced ovulation in the ploycystic ovary syndrome. N Engl J Med 1998; 338: 1876-80.
9. Jahanfar S, Eden JA, Warren P, Seppala M, Guyent N. Twin study of polycystic ovary syndrome. Fertil Steril 1995, 63: 478.
10. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ, Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, white facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-54.
11. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998, 338: 1876-80.
12. Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian p 450c 17 and activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 4075.
13. Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez - Armas O, Rivas-Santiago A, Koistinen H, et al. Insulin reduction with metformin increases luteal phase serum glycodein and insulin - like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001: 86: 1126-33.
14. Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O, et al. CO -administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial: Hum Reprod 2002; 17: 289-94.
15. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-54.
16. Arslanian SA, Lewy V, Danadian K, Rola Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance. J Clin Endocrinol Metabol 2002; 87: 1555-9.
17. Legrors, Fine Good D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-8.